Time and Venue: 11th - 13th December 2020, Guangzhou City, Guangdong Province, China
About: The conference will be held in Guangzhou, China, December 11-13th, 2020, which is sponsored by the Committee of Tumor Biomarker and Holistic Integrative Oncology Branch, Chinese Anti-Cancer Association, and hosted by The Sixth Affiliated Hospital, Sun Yat-sen University.
The theme of the conference is "innovation, transformation, cooperation and sharing". The conference will also invite many prominent scientists from China and overseas. There will be many informative lectures on current progress of cancer research and basic translating research, as well as clinical and industrial applications.
Time and Venue: 11−13 September 2020
About: The ILCA 2020 will be a fully Virtual Conference which will take place between 11-13 September and will feature a three-day programme focusing on regulatory facts and trends, practical information, and the latest developments regarding the liver cancer field. Save the date and learn more about the conference at The ILCA 2020 will be a fully Virtual Conference which will take place between 11-13 September and will feature a three-day programme focusing on regulatory facts and trends, practical information, and the latest developments regarding the liver cancer field. Save the date and learn more about the conference at https://www.ilca2020.org/.
Time and Venue: 6th - 8th December 2019, Wuhan City, Hubei Province, China
About: 2019 Chinese Academic Conference on Tumor Biomarker (CCTB) & the 13th Youth Scientists Forum on Tumor Biomarker will be held during December 6-8, 2019 in Wuhan City, Hubei Province, China. We look forward to seeing you there!
Time and Venue: 20−22 September 2019, Chicago, USA
About: The International Liver Cancer Association (ILCA) is pleased to bring its 13th Annual Conference to the beautiful city of Chicago, USA, offering a programme with a multidisciplinary and transversal approach, with the objective to encourage and stimulate scientific debate and networking between liver cancer experts from all regions.
Clinical, translational and basic researchers, physicians and allied professionals across liver cancer related disciplines will convene at ILCA 2019 to share best practices and findings, making this event the premier forum for advancing research in the pathogenesis, prevention, and treatment of liver cancer.
The conference will feature sessions on the following topics:
• The Cell of Origin of Liver Cancer
• The Patient Perspective on Cancer Treatment
• Clinical Trials
• Peri Hilar Cholangiocarcinoma
• Molecular Diversity in HCC
• Systemic Therapy
• Surgery for Primary Liver Cancer
• Imaging of HCC Response to Loco-Regional and Systemic Therapy
• Molecular Lessons Learnt from Clinical Trials in the Last Decade
• Treatment and Response
The deadline to submit your abstract is 8 April 2019 and the deadline to benefit from early registration discounts is 1 July 2019.